BIOFINA A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.4% 8.6% 6.8% 10.0% 7.9%  
Credit score (0-100)  43 30 35 23 30  
Credit rating  BBB BB BBB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Gross profit  140 49.9 42.1 22.9 18.9  
EBITDA  95.6 5.2 -1.8 -19.2 8.8  
EBIT  95.6 5.2 -1.8 -19.2 8.8  
Pre-tax profit (PTP)  95.1 5.0 -2.0 -19.7 8.7  
Net earnings  74.0 3.9 -2.0 -19.7 8.7  
Pre-tax profit without non-rec. items  95.1 5.0 -2.0 -19.7 8.7  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  16.7 20.6 18.5 -1.1 7.6  
Interest-bearing liabilities  200 198 196 191 190  
Balance sheet total (assets)  257 251 239 215 221  

Net Debt  119 144 121 167 155  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  140 49.9 42.1 22.9 18.9  
Gross profit growth  86.3% -64.4% -15.7% -45.7% -17.3%  
Employees  0 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  257 251 239 215 221  
Balance sheet change%  -4.6% -2.4% -4.7% -10.1% 2.8%  
Added value  95.6 5.2 -1.8 -19.2 8.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  3.0 4.0 -1.0 -2.0 1.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  68.2% 10.4% -4.3% -84.1% 46.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  32.8% 2.1% -0.7% -8.4% 4.0%  
ROI %  37.0% 2.4% -0.8% -9.5% 4.5%  
ROE %  51.7% 20.8% -10.4% -16.8% 7.8%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Equity ratio %  84.3% 86.0% 89.3% 87.9% 89.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  124.9% 2,773.1% -6,765.0% -870.7% 1,757.1%  
Gearing %  1,198.9% 964.8% 1,058.9% -17,020.7% 2,497.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.2% 0.1% 0.1% 0.2% 0.0%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Quick Ratio  6.1 6.7 8.9 7.8 8.9  
Current Ratio  6.2 6.9 9.1 8.0 9.1  
Cash and cash equivalent  80.8 54.0 74.8 24.0 35.3  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  209.6 208.4 206.4 181.8 190.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 5 -2 -19 9  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 5 -2 -19 9  
EBIT / employee  0 5 -2 -19 9  
Net earnings / employee  0 4 -2 -20 9